Skip to main content

Table 1 Characteristics of Patients and Main Results

From: Orthodeoxia and its implications on awake-proning in COVID-19 pneumonia

 

SUPINE RESPONDERS

SUPINE NON-RESPONDERS

Baseline characteristics

  

No (%)

14 (50)

14 (50)

Age, median (IQR)

66 (56–72)

66 (57–69)

Sex, No (%)

  

Women

1 (7.1)

5 (35.7)

Men

13 (92.9)

9 (64.3)

BMI, median (IQR)

27.5 (24.2–30.0)

28.3 (27.5–31.1)

Current smokers, No (%)

1 (7)

0 (0)

Arterial hypertension, No (%)

7 (50)

9 (64)

Type 2 Diabetes Mellitus, No (%)

1 (7)

4 (29)

SOFA score, median (IQR)

3 (3–3)

3 (2–3)

Disease course, median (IQR)

  

Days from diagnosis of infection

11.5(8–14)

9.5 (8–12)

Days from hospital admission

3.5 (2–7)

3.5 (2–6)

Days from respiratory support

2.5 (1–5)

2 (1–4)

Ventilatory settings

  

HCPAP, No (%)

11 (79)

11 (79)

HFNC, No (%)

3 (21)

3 (21)

FiO2, median (IQR)

0.5 (0.5–0.6)

0.5 (0.5–0.5)

PEEP (if HCPAP), median (IQR)

10 (10–12)

10 (10–12)

Flow (if HFNC), median (IQR)

40 (35–40)

35 (35–40)

Protocol

Seated

Supine

Prone

Seated

Supine

Prone

Starting decubitus, no (%)

2 (14)

6 (43)

6 (43)

4 (29)

5 (36)

5 (36)

Respiratory variables, median (IQR)

  

PaO2, mmHg

82.2 (73.2–101)

120 (108–149)*

139 (108–184)*

96 (67–117)

92 (74–120)

102 (68.5–125)*

PaO2/FiO2 ratio

152 (133–177)

224 (186–248)*

278 (198–336)*

192 (160–224)

186 (165–230)

204 (150–246)

PaCO2, mmHg

38 (35.9–39)

39.1 (38–43)*

37.8 (37–41)*

38.3 (34.1–40)

40.5 (35.8–42)*

39.8 (36–41)

Arterial pH

7.45 (7.44 -7.46)

7.43 (7.43 -7.45)*

7.44 (7.44 -7.46)

7.46 (7.44 -7.47)

7.45 (7.42 -7.47)*

7.44 (7.43 -7.46)

Respiratory rate, bpm

19 (17–22)

17 (15–18)*

19 (16–23)*

21.5 (18–24)

19 (16–22)*

18.5 (16–21)

Subjective variables

  

Borg dyspnea scale, median (IQR)

0 (0–0)

0 (0–0)

0 (0–0)

0 (0–0)

0 (0–0)

0 (0–1)

Discomfort, no (%)

2 (14.3)

1 (7.1)

8 (57.1)*

0 (0)

0 (0)

5 (35.7)*

Hemodynamics, median (IQR)

  

Cardiac index, L/min/m2 a

3 (3–3.2)

3.1 (3–3.3)

3.3 (3.3–3.5)*

2.8 (2.5–3.5)

2.9 (2.4–3.1)

3.1 (3–3.4)*

Stroke volume index, mL/m2 a

41 (39–42)

47 (38–48)*

46 (40–52)

39 (33–45)

50 (37–55)*

40 (37–51)

Pulse pressure, mmHg

51 (42–58)

55 (47–60)*

54 (48–70)

55 (46–78)

69 (53–90)*

71 (56- 81)

Heart rate, bpm

70 (69–77)

64 (60–71)*

68 (60–77)*

75 (67–86)

70 (60–76)*

76 (69–82)*

  1. IQR, interquartile range; BMI, body mass index (weight in kilograms divided by the square of the height in meters); SOFA, sequential organ failure assessment; HCPAP, helmet continuous positive airway pressure; HFNC, high flow nasal cannula; FiO2, fraction of inspired oxygen; PEEP, positive end expiratory pressure; PaO2, partial pressure of oxygen; mmHg, millimeters of mercury; PaCO2, partial pressure of carbon dioxide; bpm, breaths (or beats) per minute
  2. aData available from 12 patients (5 supine responders and 7 supine non-responders) equipped with non-invasive advanced hemodynamic monitoring (CNAP®). Note that changes in stroke volume are paralleled by changes in pulse pressure (its surrogate) confirming the trend of cardiac output even in patients without advanced hemodynamic monitoring
  3. *Significantly different (p < 0.05) with respect to the preceding decubitus in the table